Existing COVID-19 shots less potent against new
variants
A laboratory study showed Pfizer's COVID-19 vaccine was about
two-thirds less potent against the coronavirus variant first identified in
South Africa than it was against the original variant, according to a letter
published in The New England Journal of Medicine. Moderna also published a
letter in NEJM revealing it tested its COVID-19 vaccine against variants
discovered in South Africa, UK and Denmark and found a sixfold drop in
neutralizing antibodies when the vaccine was tested against "the full panel
of mutations."
Full Story: FiercePharma (2/18)
No comments:
Post a Comment